These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35592705)

  • 1. Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
    Xiong Y; Chen T; Yu J; Zhou H; Lu B; Chen L; Sun L; Wang C; Li S; Wu B
    Dis Markers; 2022; 2022():7840710. PubMed ID: 35592705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide linkage analysis and whole-genome sequencing identify a recurrent SMARCAD1 variant in a unique Chinese family with Basan syndrome.
    Li M; Wang J; Li Z; Zhang J; Ni C; Cheng R; Yao Z
    Eur J Hum Genet; 2016 Aug; 24(9):1367-70. PubMed ID: 26932190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of two candidate genes for Basan syndrome.
    Marks KC; Banks WR; Cunningham D; Witman PM; Herman GE
    Am J Med Genet A; 2014 May; 164A(5):1188-91. PubMed ID: 24664640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basan gets a new fingerprint: Mutations in the skin-specific isoform of SMARCAD1 cause ectodermal dysplasia syndromes with adermatoglyphia.
    Valentin MN; Solomon BD; Richard G; Ferreira CR; Kirkorian AY
    Am J Med Genet A; 2018 Nov; 176(11):2451-2455. PubMed ID: 30289605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectodermal dysplasia with congenital adermatoglyphia (Basan syndrome): Report of two cases presenting with extensive congenital milia.
    Nieto-Benito LM; Molina-López I; Feito-Rodríguez M; Martínez-González V; Suárez-Fernández R; Campos-Dominguez M
    Pediatr Dermatol; 2021 Mar; 38(2):530-532. PubMed ID: 33486784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huriez syndrome: Additional pathogenic variants supporting allelism to SMARCAD syndrome.
    Loh AYT; Špoljar S; Neo GYW; Escande-Beillard N; Leushacke M; Luijten MNH; Venkatesh B; Bonnard C; van Steensel MAM; Hamm H; Carmichael A; Rajan N; Carney TJ; Reversade B
    Am J Med Genet A; 2022 Jun; 188(6):1752-1760. PubMed ID: 35212137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous Deletion Impacting SMARCAD1 in the Original Kindred with Absent Dermatoglyphs and Associated Features (Baird, 1964).
    Chang X; Li D; Tian L; Liu Y; March M; Wang T; Hou C; Pellegrino R; Levy R; Jen M; Soccio R; Sleiman P; Hakonarson H; Castelo-Soccio L
    J Pediatr; 2018 Mar; 194():248-252.e2. PubMed ID: 29269196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two
    Elhaji Y; van Henten TMA; Ruivenkamp CAL; Nightingale M; Santen GW; Vos LE; Hull PR
    JID Innov; 2021 Sep; 1(3):100022. PubMed ID: 34909722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basan syndrome in a family from South India: a novel SMARCAD1 variant.
    Mathews I; Wagh S; Baby A; Chandrashekar L; Dalal A
    Clin Exp Dermatol; 2024 Mar; 49(4):437-440. PubMed ID: 37966719
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
    Lee SY; Lee M; Yu DS; Lee YB
    J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinoma in an autosomal-recessive Adams-Oliver syndrome patient with a novel frameshift pathogenic variant in the EOGT gene.
    Lukas ML; Harald G; Sanz J; Trippel M; Sabina G; Jochen R
    Am J Med Genet A; 2022 Nov; 188(11):3318-3323. PubMed ID: 36059114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel heterozygous splice-altering mutation in HFM1 may be a cause of premature ovarian insufficiency.
    Zhe J; Chen S; Chen X; Liu Y; Li Y; Zhou X; Zhang J
    J Ovarian Res; 2019 Jul; 12(1):61. PubMed ID: 31279343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational landscape of aggressive cutaneous squamous cell carcinoma.
    Pickering CR; Zhou JH; Lee JJ; Drummond JA; Peng SA; Saade RE; Tsai KY; Curry JL; Tetzlaff MT; Lai SY; Yu J; Muzny DM; Doddapaneni H; Shinbrot E; Covington KR; Zhang J; Seth S; Caulin C; Clayman GL; El-Naggar AK; Gibbs RA; Weber RS; Myers JN; Wheeler DA; Frederick MJ
    Clin Cancer Res; 2014 Dec; 20(24):6582-92. PubMed ID: 25303977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9813418. PubMed ID: 37387737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in a skin-specific isoform of SMARCAD1 causes autosomal-dominant adermatoglyphia.
    Nousbeck J; Burger B; Fuchs-Telem D; Pavlovsky M; Fenig S; Sarig O; Itin P; Sprecher E
    Am J Hum Genet; 2011 Aug; 89(2):302-7. PubMed ID: 21820097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCAD1 Haploinsufficiency Underlies Huriez Syndrome and Associated Skin Cancer Susceptibility.
    Günther C; Lee-Kirsch MA; Eckhard J; Matanovic A; Kerscher T; Rüschendorf F; Klein B; Berndt N; Zimmermann N; Flachmeier C; Thuß T; Lucas N; Marenholz I; Esparza-Gordillo J; Hübner N; Traupe H; Delaporte E; Lee YA
    J Invest Dermatol; 2018 Jun; 138(6):1428-1431. PubMed ID: 29409814
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations in GRHL2 result in an autosomal-recessive ectodermal Dysplasia syndrome.
    Petrof G; Nanda A; Howden J; Takeichi T; McMillan JR; Aristodemou S; Ozoemena L; Liu L; South AP; Pourreyron C; Dafou D; Proudfoot LE; Al-Ajmi H; Akiyama M; McLean WH; Simpson MA; Parsons M; McGrath JA
    Am J Hum Genet; 2014 Sep; 95(3):308-14. PubMed ID: 25152456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectodermal dysplasia-skin fragility syndrome: Two new cases and review of this desmosomal genodermatosis.
    Doolan BJ; Gomaa NS; Fawzy MM; Dogheim NN; Liu L; Mellerio JE; Onoufriadis A; McGrath JA
    Exp Dermatol; 2020 Jun; 29(6):520-530. PubMed ID: 32248567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.